Converge International has acquired HeadUp Labs
The shareholders of HeadUp Labs have sold the company to Converge International. The acquisition of HeadUp is a strong fit with Converge’s digital product growth strategy, and has the potential to create a fully integrated and holistic preventative workplace mental health, safety, wellbeing and engagement product.
Converge is Australia’s most established B2B workplace mental health and wellbeing service provider, enabling corporate and government organizations to provide their employees with the wellbeing support they need, reducing risk, improving employee resilience and increasing workforce participation.
Headquartered in Melbourne, Australia, HeadUp Labs is a physical and mental digital health platform. It harnesses the power of wearable technology, data science, AI and machine learning to help employees and policy holders identify the areas of their health that they need to improve. HeadUp Labs has offices around the world and the team has 20+ years of experience in healthtech and insurtech.
Oaklins’ team in Australia acted as M&A advisor to Converge International on the acquisition of HeadUp Labs.
Terry Winters
Chairman, Converge International
Talk to the deal team
Related deals
Skynamo has been acquired by Klipboard
Klipboard, a global provider of vertical business management software, has completed the acquisition of Skynamo, a market-leading mobile field sales platform used by manufacturers, wholesalers and distributors worldwide. The acquisition adds Skynamo’s award-winning field sales platform to Klipboard’s portfolio and enhances its ability to support wholesalers, distributors and retailers in managing complex operations across many industries.
Learn moreOaklins DeSilva+Phillips represents ProcessUnity in its recent transaction
Oaklins DeSilva+Phillips was pleased to represent our client ProcessUnity, a leading provider of third-party risk management (TPRM) software, in its recently announced transaction with S&P Global.
Learn moreInstituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn more